These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 969587)

  • 1. [Comparative studies on the incidence and course of primary schizophrenia].
    Waldmann KD; Greger J; Totzauer S; Grimm T
    Z Arztl Fortbild (Jena); 1976 Jan; 70(1):26-9. PubMed ID: 969587
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical treatment of chronic schizophrenia in the Federal German Republic. Results and consequences].
    Hartmann W; Meyer JE
    Nervenarzt; 1974 Jan; 45(2):1-8. PubMed ID: 4858398
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinico-statistical and pharmaco-therapeutical studies of the late form of schizophrenia].
    Carrescia O; Tatarelli R
    Ann Med Nav (Roma); 1971; 76(5):518-25. PubMed ID: 5146015
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term course and prognosis in schizophrenia.
    Stephens JH
    Semin Psychiatry; 1970 Nov; 2(4):464-85. PubMed ID: 5527412
    [No Abstract]   [Full Text] [Related]  

  • 5. [The factors influencing the effectiveness of therapy in schizophrenia and the principles of patient selection for a comparative evaluation of the results of treatment (a survey of the literature)].
    Karimov RK
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):612-9. PubMed ID: 4574524
    [No Abstract]   [Full Text] [Related]  

  • 6. The relationships between psychopathology and evoked responses before, during, and after psychotropic drug treatment.
    Saletu B; Saletu M; Itil TM
    Biol Psychiatry; 1973 Feb; 6(1):45-74. PubMed ID: 4710776
    [No Abstract]   [Full Text] [Related]  

  • 7. [Symptomatic schizophrenia in disseminated lupus erythematosus].
    Foerster K; Foerster G; Glatzel J
    Nervenarzt; 1976 Apr; 47(4):265-7. PubMed ID: 1272486
    [No Abstract]   [Full Text] [Related]  

  • 8. [Better prognosis due to new treatment approaches. Therapy of schizophrenia in 2002].
    Janssen B; Gaebel W
    MMW Fortschr Med; 2002 May; Suppl 2():72-6, 78. PubMed ID: 12070858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current evolution of schizophrenia. Apropos of the evolution of 35 young schizophrenics followed for more than 10 years].
    Lambert PA; Midenet M
    Ann Med Psychol (Paris); 1975 Dec; 2(5):873-91. PubMed ID: 1232901
    [No Abstract]   [Full Text] [Related]  

  • 10. [Features of the course of paroxysmal schizophrenia in advanced age].
    Shesmerneva SE
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(9):1362-8. PubMed ID: 5700610
    [No Abstract]   [Full Text] [Related]  

  • 11. [Action of flupentixol decanoate in chronic psychoses of the schizophrenic type].
    Evrard E; Heusghem C; Molders V; Plomteux G; Lebas A
    Acta Psychiatr Belg; 1972 Sep; 72(5):573-94. PubMed ID: 4669430
    [No Abstract]   [Full Text] [Related]  

  • 12. [Factors affecting the process of the recurrence of schizophrenia (a review)].
    Davtian SE
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1992; 92(3):115-20. PubMed ID: 1359721
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessment of drugs in schizophrenia. Assessment of psychiatric and social state. 20V.
    Leff J
    Br J Clin Pharmacol; 1976 Jun; 3(3 Suppl 2):385-90. PubMed ID: 987793
    [No Abstract]   [Full Text] [Related]  

  • 14. [Problem of chronicity of endogenous psychoses].
    Vencovský E
    Cesk Psychiatr; 1971 Apr; 67(2):65-72. PubMed ID: 5554017
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug withdrawal symptoms following cessation of prolonged neuroleptic therapy].
    Krystof J; Zyg J; Mitkiewicz S; Kaczyński J
    Psychiatr Pol; 1971; 5(4):417-23. PubMed ID: 5112317
    [No Abstract]   [Full Text] [Related]  

  • 16. [The Wartegg-Sign-Test in schizophrenics].
    Knorr W; Rennert H
    Fortschr Neurol Psychiatr Grenzgeb; 1966 May; 34(5):276-96. PubMed ID: 5339269
    [No Abstract]   [Full Text] [Related]  

  • 17. [Environment and the course of chronic schizophrenia].
    Bizoń E; Stańczak T
    Psychiatr Pol; 1974 May; 8(3):287-93. PubMed ID: 4839846
    [No Abstract]   [Full Text] [Related]  

  • 18. Meharry Community Mental Health Center. Schizophrenia.
    J Tenn Med Assoc; 1972 Apr; 65(4):333-6. PubMed ID: 5020990
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drawings by schizophrenic patients as a prognostic factor in the evaluation of their mental state].
    Bartoszewski J; Wojciechowski J
    Psychiatr Pol; 1971; 5(2):153-9. PubMed ID: 4930730
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic pathomorphology during the terminal stages of schizophrenia].
    Vartanian FE
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(2):250-7. PubMed ID: 5661308
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.